• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于清除率概念对家兔中甲苯磺丁脲-磺胺相互作用的动力学分析。根据体外血浆蛋白结合和代谢预测种属差异。

Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.

作者信息

Sugita O, Sawada Y, Sugiyama Y, Iga T, Hanano M

出版信息

Drug Metab Dispos. 1984 Jan-Feb;12(1):131-8.

PMID:6141904
Abstract

The interaction between tolbutamide (TB) and sulfonamide (SA) in rabbits was quantitatively investigated by both in vivo and in vitro experiments, and the mechanisms of species difference between rabbits and rats were analyzed by comparing the two total body clearances (CLtot) obtained from in vivo and in vitro studies. The sulfonamides used were sulfaphenazole (SP) and sulfadimethoxine (SDM). In vivo CLtot of TB was changed little by SA in rabbits, which was contrary to the phenomenon seen in rats, i.e. CLtot was markedly decreased by SA in rats (Sugita et al., Biochem. Pharmacol., 30, 3347, 1981). The total body clearance defined as CL in vitro tot.pred was predicted for TB in the presence and absence of SA by the equation: CL in vitro tot.pred congruent to fB CL in vitro int, where fB is the blood-free fraction and CL in vitro int is the hepatic intrinsic clearance of unbound drug obtained from in vitro experiments using liver microsomal fraction. A comparatively good agreement was observed between the two CLtot obtained from in vivo and in vitro data. The analysis in rabbits based on these in vitro experiments showed that the small gross changes of in vivo CLtot induced by SA were due to the compensative changes of two factors, i.e. fB and CL in vitro int which in the presence of SA were approximately 200 and 50% of the control, respectively. However, in rats, the marked decrease of in vivo CLtot induced by SA was explained by the greater degree of the decrease in CL in vitro int than that of the increase in fB.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过体内和体外实验对家兔中甲苯磺丁脲(TB)与磺胺类药物(SA)之间的相互作用进行了定量研究,并通过比较体内和体外研究获得的两种总体清除率(CLtot)分析了家兔和大鼠之间物种差异的机制。所使用的磺胺类药物为磺胺苯吡唑(SP)和磺胺二甲氧嘧啶(SDM)。在家兔中,SA对TB的体内CLtot影响很小,这与在大鼠中观察到的现象相反,即在大鼠中SA会使CLtot显著降低(杉田等人,《生物化学与药理学》,30,3347,1981)。通过以下公式预测了存在和不存在SA时TB的体外总体清除率(定义为CL体外tot.pred):CL体外tot.pred ≈ fB CL体外int,其中fB是无血分数,CL体外int是使用肝微粒体部分通过体外实验获得的未结合药物的肝内在清除率。体内和体外数据获得的两种CLtot之间观察到了较好的一致性。基于这些体外实验对家兔的分析表明,SA引起的体内CLtot的微小总体变化是由于两个因素的补偿性变化,即fB和CL体外int,在存在SA的情况下,它们分别约为对照的200%和50%。然而,在大鼠中,SA引起的体内CLtot的显著降低可以通过CL体外int的降低程度大于fB的增加程度来解释。(摘要截断于250字)

相似文献

1
Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.基于清除率概念对家兔中甲苯磺丁脲-磺胺相互作用的动力学分析。根据体外血浆蛋白结合和代谢预测种属差异。
Drug Metab Dispos. 1984 Jan-Feb;12(1):131-8.
2
Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection.奎尼丁对R-华法林10-羟基化作用的影响:种属差异及清除率预测
J Pharmacol Exp Ther. 2004 Oct;311(1):307-14. doi: 10.1124/jpet.104.069955. Epub 2004 May 26.
3
Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.通过体内动物实验以及利用动物和人类肝脏微粒体进行的体外代谢研究预测人体肝脏清除率。
Drug Metab Dispos. 2001 Oct;29(10):1316-24.
4
Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.基于体外实验预测甲苯磺丁脲与多种磺胺类药物在人体内的药物相互作用。
Drug Metab Dispos. 2000 Apr;28(4):475-81.
5
Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.体外系统对体内处置的预测:利用大鼠肝微粒体和肝细胞数据预测苯妥英钠和甲苯磺丁脲的清除率
J Pharmacol Exp Ther. 1995 Aug;274(2):761-6.
6
Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).实验性抗癌药物5,6-二甲基呫吨酮-4-乙酸(DMXAA)代谢及药代动力学的性别差异
Cancer Chemother Pharmacol. 2002 Feb;49(2):126-32. doi: 10.1007/s00280-001-0383-5. Epub 2001 Oct 24.
7
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.强效HIV-1逆转录酶抑制剂L-738,372代谢的种属差异。大鼠、狗、猴子和人类的体内及体外研究。
Drug Metab Dispos. 1995 Jul;23(7):688-95.
8
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.评估冷冻保存的人肝细胞作为微粒体的替代体外系统用于预测代谢清除率。
Drug Metab Dispos. 2007 Feb;35(2):293-301. doi: 10.1124/dmd.106.011569. Epub 2006 Nov 28.
9
Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.药物相互作用的基于生理学的药代动力学:大鼠中甲苯磺丁脲-磺胺类药物相互作用的研究
J Pharmacokinet Biopharm. 1982 Jun;10(3):297-316. doi: 10.1007/BF01059263.
10
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.一种基于肝细胞和微粒体体外内在清除率数据预测人体肝脏代谢清除率的统一模型。
Drug Metab Dispos. 2005 Sep;33(9):1304-11. doi: 10.1124/dmd.105.004259. Epub 2005 Jun 2.

引用本文的文献

1
Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver.基于生理药代动力学,从体外数据对体内药物相互作用进行定量预测:利用肝脏入口处抑制剂的最大非结合浓度
Pharm Res. 2000 Mar;17(3):336-43. doi: 10.1023/a:1007509324428.
2
Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.体内取代咪唑类药物对甲苯磺丁脲代谢的抑制作用:构效关系的证据。
Br J Pharmacol. 1985 May;85(1):121-6. doi: 10.1111/j.1476-5381.1985.tb08838.x.